Clinical Trials Directory

Trials / Sponsors / Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Multiple Sclerosis, Walking Impairment
Phase 32018-07-18
CompletedSafety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment
Walking Impairment, Multiple Sclerosis
Phase 32018-03-29
CompletedSafety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
Walking Impairment, Multiple Sclerosis
Phase 22015-05-01
CompletedEfficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
Dyskinesia, Levodopa-Induced Dyskinesia (LID), Parkinson's Disease (PD)
Phase 32014-10-01
TerminatedEfficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LI
Parkinson's Disease, Levodopa Induced Dyskinesias (LID)
Phase 32014-08-18
TerminatedEfficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Parkinson's Disease, Levodopa Induced Dyskinesia (LID)
Phase 32014-07-30
CompletedOpen-Label Safety Study of ADS-5102 in PD Patients With LID
Dyskinesia, Levodopa Induced Dyskinesia (LID), Parkinson's Disease (PD)
Phase 32014-07-01
CompletedADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Dyskinesia, Levodopa Induced Dyskinesia (LID), Parkinson's Disease
Phase 32014-05-01
CompletedExtended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Dyskinesia, Levodopa Induced Dyskinesia, Parkinson's Disease
Phase 2 / Phase 32011-07-01
CompletedOral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
Influenza
Phase 22009-09-01